This case showed aggressive clinical features and was reclassified as malignant GCTST because the immunohistochemical examination demonstrated expression of RUNX2 and SATB2, displaying osteogenic differentiation. This evidence concerns the gene RUNX2 and giant cell tumor of soft tissue.